Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Bristol-Myers Squibb Company(BMY) | 140,000 | 446,900 | +306,900 | $7.18M | $24.24M | 9.34% | +$17.05M |
| Gilead Sciences, Inc.(GILD) | 0 | 265,436 | +265,436 | $0 | $19.44M | 7.50% | +$19.44M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 1,061,668 | 1,135,710 | +74,042 | $11.08M | $16.02M | 6.18% | +$4.94M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 0 | 16,360 | +16,360 | $0 | $15.75M | 6.07% | +$15.75M |
| BioMarin Pharmaceutical Inc.(BMRN) | 129,906 | 175,000 | +45,094 | $12.53M | $15.28M | 5.89% | +$2.76M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 289,366 | +289,366 | $0 | $12.54M | 4.84% | +$12.54M |
| Royalty Pharma plcCL A(RPRX) | 370,000 | 411,540 | +41,540 | $10.39M | $12.50M | 4.82% | +$2.11M |
| Sarepta Therapeutics, Inc.(SRPT) | 0 | 94,379 | +94,379 | $0 | $12.22M | 4.71% | +$12.22M |
| Acadia Pharmaceuticals Inc | 330,973 | 658,409 | +327,436 | $10.36M | $12.17M | 4.69% | +$1.81M |
| Biogen Inc.(BIIB) | 0 | 52,000 | +52,000 | $0 | $11.21M | 4.32% | +$11.21M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 1,521,812 | 2,105,459 | +583,647 | $9.12M | $10.70M | 4.12% | +$1.58M |
| Halozyme Therapeutics, Inc.(HALO) | 240,448 | 255,049 | +14,601 | $8.89M | $10.38M | 4.00% | +$1.49M |
| Perrigo Company plcSHS(PRGO) | 260,000 | 322,114 | +62,114 | $8.37M | $10.37M | 4.00% | +$2.00M |
| Exelixis, Inc.(EXEL) | 462,305 | 398,762 | -63,543 | $11.09M | $9.46M | 3.65% | -$1.63M |
| Avadel Pharmaceuticals PlcADR | 0 | 541,926 | +541,926 | $0 | $9.15M | 3.53% | +$9.15M |
| Eli Lilly and Company(LLY) | 0 | 11,040 | +11,040 | $0 | $8.59M | 3.31% | +$8.59M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 288,580 | +288,580 | $0 | $8.44M | 3.25% | +$8.44M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 107,500 | 120,185 | +12,685 | $6.73M | $8.19M | 3.16% | +$1.46M |
| Arcellx Inc COMMON STOCK | 0 | 107,000 | +107,000 | $0 | $7.44M | 2.87% | +$7.44M |
| Insmed Incorporated(INSM) | 413,499 | 227,337 | -186,162 | $12.81M | $6.17M | 2.38% | -$6.65M |
| Viridian Therapeutics, Inc.(VRDN) | 307,721 | 278,638 | -29,083 | $6.70M | $4.88M | 1.88% | -$1.82M |
| Legend Biotech CorporationADS(LEGN) | 0 | 79,830 | +79,830 | $0 | $4.48M | 1.73% | +$4.48M |
| Kyverna Therapeutics, Inc.(KYTX) | 0 | 166,514 | +166,514 | $0 | $4.14M | 1.59% | +$4.14M |
| Pliant Therapeutics, Inc.(PLRX) | 0 | 194,119 | +194,119 | $0 | $2.89M | 1.12% | +$2.89M |
| Cabaletta Bio, Inc.(CABA) | 230,000 | 157,964 | -72,036 | $5.22M | $2.69M | 1.04% | -$2.53M |
| Amgen Inc.(AMGN) | 57,381 | 0 | -57,381 | $16.53M | $0 | — | -$16.53M |
| Amicus Therapeutics Inc COM | 947,418 | 0 | -947,418 | $13.44M | $0 | — | -$13.44M |
| Apellis Pharmaceuticals Inc COM | 108,000 | 0 | -108,000 | $6.46M | $0 | — | -$6.46M |
| Arcus Biosciences, Inc.(RCUS) | 192,667 | 0 | -192,667 | $3.68M | $0 | — | -$3.68M |
| BridgeBio Pharma, Inc.(BBIO) | 103,324 | 0 | -103,324 | $4.17M | $0 | — | -$4.17M |
| Iovance Biotherapeutics, Inc.(IOVA) | 677,350 | 0 | -677,350 | $5.51M | $0 | — | -$5.51M |
| Merck & Co., Inc.(MRK) | 136,098 | 0 | -136,098 | $14.84M | $0 | — | -$14.84M |
| Pfizer Inc.(PFE) | 265,000 | 0 | -265,000 | $7.63M | $0 | — | -$7.63M |
| Prestige Consumer Healthcare Inc.(PBH) | 85,000 | 0 | -85,000 | $5.20M | $0 | — | -$5.20M |
| Roivant Sciences Ltd.SHS(ROIV) | 1,000,000 | 0 | -1,000,000 | $11.23M | $0 | — | -$11.23M |